Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001996442-25-000002
Filing Date
2025-06-23
Accepted
2025-06-23 17:03:17
Documents
1
Effectiveness Date
2025-06-23
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6395
  Complete submission text file 0001996442-25-000002.txt   7418
Mailing Address 3033 IRVING BLVD. DALLAS TX 75247
Business Address 3033 IRVING BLVD. DALLAS TX 75247 469-600-6603
EtiraRX, Inc. (Filer) CIK: 0001996442 (see all company filings)

EIN.: 863808286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-549619 | Film No.: 251065746